Quadrature Capital’s Mesa Laboratories MLAB Stock Holding History

Quadrature Capital’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$765K	Sell	7,682 -1,011	-12%	-$102K	0.01%	834
2026 Q1	$769K	Sell	8,693 -4,835	-36%	-$417K	0.01%	654
2025 Q4	$1.06M	Buy	+13,528	New	+$1.03M	0.01%	508
2025 Q1	–	Sell	-5,703	Closed	-$754K	–	1326
2024 Q4	$754K	Buy	5,703 +4,003	+235%	+$491K	0.02%	490
2024 Q3	$221K	Buy	+1,700	New	+$200K	0.01%	745
2022 Q4	–	Sell	-8,969	Closed	-$1.27M	–	1028
2022 Q3	$1.27M	Buy	+8,969	New	+$1.64M	0.04%	337
2021 Q4	–	Sell	-2,568	Closed	-$779K	–	849
2021 Q3	$779K	Buy	2,568 +975	+61%	+$277K	0.03%	293
2021 Q2	$430K	Buy	+1,593	New	+$404K	0.02%	544

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Quadrature Capital's MLAB Position: Q2 2026 in Review

Quadrature Capital reduced its Mesa Laboratories (MLAB) stake by 12% in Q2 2026, selling an estimated $102K and leaving 7,682 shares worth $765K. The position accounts for 0.01% of the portfolio, ranked #834.

Quadrature Capital first reported a position in MLAB in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.27M in Q3 2022. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Quadrature Capital held 7,682 shares of Mesa Laboratories worth $765K as of Q2 2026.
Quadrature Capital sold 1,011 Mesa Laboratories shares in Q2 2026, an estimated $102K.
Mesa Laboratories made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #834 holding.
Quadrature Capital first reported a position in Mesa Laboratories in Q2 2021 and has held it in 8 quarters since.
Quadrature Capital's Mesa Laboratories position peaked at $1.27M in Q3 2022.
159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.